45 related articles for article (PubMed ID: 38505696)
21. The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.
Roach M; Land N; Hernandez J; Rau R; Chou JW; Hickson SS; Rollmann DF; Maclean JR
Int J Clin Pract; 2024; 2024():5877687. PubMed ID: 38505696
[TBL] [Abstract][Full Text] [Related]
22. Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care.
Cross AJ; Thomas D; Liang J; Abramson MJ; George J; Zairina E
Cochrane Database Syst Rev; 2022 May; 5(5):CD012652. PubMed ID: 35514131
[TBL] [Abstract][Full Text] [Related]
23. Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review.
Fu Y; Chapman EJ; Boland AC; Bennett MI
Palliat Med; 2022 May; 36(5):770-782. PubMed ID: 35311415
[TBL] [Abstract][Full Text] [Related]
24. Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.
Zhang Z; Yang S; Ma Y; Zhou H; Wu X; Han J; Hou J; Hao L; Spicer JD; Koh YW; Provencio M; Reguart N; Mitsudomi T; Wang Q
Transl Lung Cancer Res; 2021 Jun; 10(6):2715-2732. PubMed ID: 34295672
[TBL] [Abstract][Full Text] [Related]
25. Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Burgers JS; Anzueto A; Black PN; Cruz AA; Fervers B; Graham ID; Metersky M; Woodhead M; Yawn BP;
Proc Am Thorac Soc; 2012 Dec; 9(5):304-10. PubMed ID: 23256175
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.
Kankaanranta H; Harju T; Kilpeläinen M; Mazur W; Lehto JT; Katajisto M; Peisa T; Meinander T; Lehtimäki L
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):291-307. PubMed ID: 25515181
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review.
Bennett WL; Odelola OA; Wilson LM; Bolen S; Selvaraj S; Robinson KA; Bass EB; Puhan MA
Ann Intern Med; 2012 Jan; 156(1 Pt 1):27-36. PubMed ID: 22213492
[TBL] [Abstract][Full Text] [Related]
28. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].
;
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2037-2074. PubMed ID: 37455124
[TBL] [Abstract][Full Text] [Related]
29. [Evidence-based practice guideline for unresectable advanced lung cancer in 2003].
Fukuoka M; Kurata T; Yamamoto N
Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):412-6. PubMed ID: 15303441
[TBL] [Abstract][Full Text] [Related]
30. Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.
Cheng JS; Lee MJ; Massicotte E; Ashman B; Gruenberg M; Pilcher LE; Skelly AC
Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S144-63. PubMed ID: 21952186
[TBL] [Abstract][Full Text] [Related]
31. Identifying target audiences: who are the guidelines for? : article 1 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Yawn BP; Akl EA; Qaseem A; Black P; Campos-Outcalt D;
Proc Am Thorac Soc; 2012 Dec; 9(5):219-24. PubMed ID: 23256162
[TBL] [Abstract][Full Text] [Related]
32. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
Li S; Vandvik PO; Lytvyn L; Guyatt GH; Palmer SC; Rodriguez-Gutierrez R; Foroutan F; Agoritsas T; Siemieniuk RAC; Walsh M; Frere L; Tunnicliffe DJ; Nagler EV; Manja V; Åsvold BO; Jha V; Vermandere M; Gariani K; Zhao Q; Ren Y; Cartwright EJ; Gee P; Wickes A; Ferns L; Wright R; Li L; Hao Q; Mustafa RA
BMJ; 2021 May; 373():n1091. PubMed ID: 33975892
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines.
Ries AL; Bauldoff GS; Carlin BW; Casaburi R; Emery CF; Mahler DA; Make B; Rochester CL; Zuwallack R; Herrerias C
Chest; 2007 May; 131(5 Suppl):4S-42S. PubMed ID: 17494825
[TBL] [Abstract][Full Text] [Related]
34. Mapping of Modifiable Factors with Interdisciplinary Chronic Obstructive Pulmonary Disease (COPD) Guidelines Adherence to the Theoretical Domains Framework: A Systematic Review.
Issac H; Moloney C; Taylor M; Lea J
J Multidiscip Healthc; 2022; 15():47-79. PubMed ID: 35046662
[TBL] [Abstract][Full Text] [Related]
35. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Fabbri LM; Boyd C; Boschetto P; Rabe KF; Buist AS; Yawn B; Leff B; Kent DM; Schünemann HJ;
Proc Am Thorac Soc; 2012 Dec; 9(5):274-81. PubMed ID: 23256171
[TBL] [Abstract][Full Text] [Related]
36. Optimizing chronic disease management mega-analysis: economic evaluation.
Path-Theta Collaboration
Ont Health Technol Assess Ser; 2013; 13(13):1-148. PubMed ID: 24228076
[TBL] [Abstract][Full Text] [Related]
37. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
[TBL] [Abstract][Full Text] [Related]
38. Clinical Practice Guideline: Tonsillectomy in Children (Update)-Executive Summary.
Mitchell RB; Archer SM; Ishman SL; Rosenfeld RM; Coles S; Finestone SA; Friedman NR; Giordano T; Hildrew DM; Kim TW; Lloyd RM; Parikh SR; Shulman ST; Walner DL; Walsh SA; Nnacheta LC
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):187-205. PubMed ID: 30921525
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
